• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenethylamines

Introduction to {2-3-(benzyloxy)phenylethyl}(methyl)amine (CAS No. 475086-52-3)

{2-3-(benzyloxy)phenylethyl}(methyl)amine is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, identified by its CAS number 475086-52-3, belongs to a class of molecules that exhibit promising biological activities, making it a subject of intense study in synthetic chemistry and medicinal chemistry. The structural features of this compound, particularly the presence of a benzyloxy group and a phenethyl moiety, contribute to its unique chemical properties and potential therapeutic applications.

The benzyloxy group, characterized by its aromatic ring structure linked to an oxygen atom, plays a crucial role in modulating the reactivity and solubility of the molecule. This group is often employed in medicinal chemistry to enhance binding affinity and metabolic stability. In contrast, the phenethyl moiety, which consists of a phenyl ring attached to an ethyl chain, is known for its ability to interact with various biological targets. These structural components collectively contribute to the compound's potential as a pharmacological agent.

Recent advancements in the field of drug discovery have highlighted the importance of targeting specific biological pathways to develop novel therapeutic interventions. {2-3-(benzyloxy)phenylethyl}(methyl)amine has been identified as a compound with the potential to interact with multiple receptors and enzymes, suggesting its utility in addressing complex diseases. Studies have shown that this molecule can modulate neurotransmitter activity, making it a candidate for further exploration in the treatment of neurological disorders.

One of the most compelling aspects of {2-3-(benzyloxy)phenylethyl}(methyl)amine is its synthetic accessibility. The presence of well-defined functional groups allows for modifications that can fine-tune its biological activity. Researchers have utilized various synthetic strategies to derive analogs of this compound, each with distinct properties that may enhance their efficacy in preclinical models. These efforts underscore the compound's significance as a scaffold for drug development.

The pharmacokinetic profile of {2-3-(benzyloxy)phenylethyl}(methyl)amine is another area of interest. Initial studies indicate that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) properties, which are critical for its potential clinical application. The benzyloxy group contributes to its solubility in both aqueous and lipid environments, facilitating its transport across biological membranes. Additionally, the phenethyl moiety influences its metabolic pathways, potentially leading to reduced toxicity and improved patient tolerance.

In vitro studies have demonstrated that {2-3-(benzyloxy)phenylethyl}(methyl)amine interacts with several key targets relevant to human health. For instance, it has been shown to bind to serotonin receptors, which are implicated in mood regulation and cognitive function. Furthermore, preliminary data suggest that this compound may exhibit anti-inflammatory properties by modulating cytokine production and immune cell responses. These findings highlight its potential as a therapeutic agent for conditions such as depression and chronic inflammation.

The development of novel drugs often involves rigorous testing in animal models to assess efficacy and safety before human trials can begin. {2-3-(benzyloxy)phenylethyl}(methyl)amine has undergone several preclinical studies that provide insights into its pharmacological effects. In rodent models, this compound has demonstrated dose-dependent improvements in behavioral tasks associated with anxiety and depression. These results are particularly encouraging given the growing need for alternative treatments that offer improved efficacy over existing options.

Advances in computational chemistry have also played a pivotal role in understanding the interactions between {2-3-(benzyloxy)phenylethyl}(methyl)amine and biological targets. Molecular modeling techniques have been employed to predict binding affinities and identify key residues involved in receptor interactions. These simulations provide valuable insights into the compound's mechanism of action and guide further optimization efforts.

The future direction of research on {2-3-(benzyloxy)phenylethyl}(methyl)amine includes exploring its potential in combination therapies. By pairing this compound with other agents that target different pathways, researchers aim to achieve synergistic effects that could enhance therapeutic outcomes. Additionally, investigating its role in drug delivery systems may lead to improved formulations that enhance bioavailability and reduce side effects.

In conclusion, {2-3-(benzyloxy)phenylethyl}(methyl)amine (CAS No. 475086-52-3) represents a promising candidate for further development in pharmaceutical research. Its unique structural features, combined with favorable pharmacokinetic properties and demonstrated biological activity, make it an attractive scaffold for drug discovery. As research continues to uncover new therapeutic applications, this compound is poised to play a significant role in addressing unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)